ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program
Go back to ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program| IMMUNOCELLULAR THERAPEUTICS, LTD. (AMEX: IMUC) | Delayed: 0.16 +0.03 (23.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.13 | 52 Week High | $0.53 | |||
| Open | $0.16 | 52 Week Low | $0.08 | |||
| Day High | $0.16 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $-0.14 | |||
| Volume | 248 | |||||
